Class action trial claims it was ‘negligent’ for the ship to sail as it had insufficient medical supplies to combat an outbreak
A class action trial has begun against the operators of the Ruby Princess which sailed from Sydney on 8 March 2000 with 2,641 passengers on board. Twenty-eight people died after contracting Covid onboard the cruise ship.A class action trial has begun against the operators of the Ruby Princess which sailed from Sydney on 8 March 2000 with 2,641 passengers on board. Twenty-eight people died after contracting Covid onboard the cruise ship.
The claim was made in opening submissions of a class action against Carnival PLC – operators of the ship which sailed from Sydney on the evening of 8 March 2020, for New Zealand with 2,641 passengers on board.The ship eventually turned around because of the number of cases. When it finally docked on 19 March, crew lined the gangway as passengers – some seen coughing and spluttering – left the ship, catching trains, buses and even overseas flights to get home.
“What occurred was not an accident, it was something very likely to have occurred,” he told the court. Pike said the two other ships in the company’s fleet had suffered outbreaks – including 700 cases and seven deaths on the infamous
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
No 10 rejects reports that Braverman could make cannabis class ASpokesperson says ‘no plans’ to reclassify drug despite claims that home secretary supports move
Read more »
‘Not having a big impact’: COVID drug fails to beat placebo in major trialPreliminary findings from a large trial suggest a blockbuster COVID-19 antiviral works no better than a placebo – furthering concerns swirling about the drug.
Read more »
‘Not having a big impact’: COVID drug fails to beat placebo in major trialPreliminary findings from a large trial suggest a blockbuster COVID-19 antiviral works no better than a placebo – furthering concerns already swirling about the drug | liammannix
Read more »
‘Not having a big impact’: COVID drug fails to beat placebo in major trialPreliminary findings from a large trial suggest a blockbuster COVID-19 antiviral works no better than a placebo – furthering concerns already swirling about the drug. | By Liam Mannix covid liammannix
Read more »